AKT1 and cancer: The PAM signaling pathway involves numerous feedback loops, compensatory pathways, and crosstalk nodes with other signal transduction axes that hamper the inhibition of PI3K, AKT, mTORC1, mTORC2, and PDK1 in cancer.